Routine evaluation of clinical and biochemical markers, including SOFA and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, pneumonia, and C-reactive protein (CRP) levels, may aid in early risk stratification. This evidence concerns the gene CRP and pneumonia.